Our immune system is capable of recognising and effectively eliminating tumours. However, tumours employ multiple mechanisms to evade surveillance and destruction by anti-tumour (cancer-killing) immune cells. One of the key strategies tumours use to escape immune surveillance is by activating the negative regulators of anti-tumour immunity. Our research aims to understand the negative regulation of anti-tumour immunity by a specialised immune cell population known as regulatory T cells (Tregs). The primary function of Tregs is to suppress harmful inflammation and uncontrolled immune responses in the context of autoimmunity. However, tumours have evolved to exploit the immune-suppressive function of Tregs to shield themselves from immune attack. By investigating the fundamental biology of Tregs, we aim to identify strategies to target these cells to enhance anti-tumour immunity and improve the efficacy of immunotherapy interventions in cancer treatment.
Current projects
Lab members
Dr Tabinda Hussain, Postdoctoral fellow
Dr Tobias Poch, Postdoctoral fellow
Ms Adelynn Tang, PhD student
Ms Fernanda Cadoso de Deus, PhD student
Mr Jian Wu, PhD student
Mr Jayendra Singh, PhD student
Mr Emerson Achari, Master's student